pembrolizumab,vibostolimab,favezelimab
merck
['mibc', 'pembro', 'key,note,57', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'bladder']
pembrolizumab monotherapy for pts with high-risk nonmuscle-invasive #bladdercancer unresponsive to bcg: results from cohort b of the phase 2 #keynote057 trial. presented by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology